Endometrial Cancer: Clinical Outcomes and Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 130
Special Issue Editor
Special Issue Information
Dear Colleagues,
Endometrial cancer (EC) is one of the most common gynecologic cancers with an increasing incidence and death. The predicted EC death (~13,030 deaths/year) is similar to the fatal ovarian cancer death (~13,270 deaths/year). However, this disease is an understudied disease. There is still a lot of progress to be made in order to provide individualized treatments for every patient.
This Special Issue aims to collate original research articles and reviews on endometrial cancer with specific attention paid to clinical outcomes and management. It highlights the latest research findings, diagnostic techniques, treatment options, and prognostic factors in clinical efforts not yet in routine use that could improve the outcomes and management of women with endometrial cancer.
We hope that experts and researchers from around the world share their knowledge and insights into the clinical management and outcomes of patients with endometrial cancer. This Special Issue will provide a platform for discussing the challenges faced in diagnosing and treating endometrial cancer, as well as exploring potential solutions and future directions for research.
Overall, this Special Issue on "Endometrial Cancer: Clinical Outcomes and Management" offers a comprehensive and up-to-date overview of the current state of knowledge in this field, with the ultimate goal of advancing the understanding and management of endometrial cancer.
Dr. Shujie Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer staging update
- endometrial cancer driver genes
- endometrial treatment overview
- novel endometrial cancer treatment (clinical trials)
- novel endometrial cancer target
- risk factors for recurrence
- resistance mechanisms
- immunotherapy in endometrial cancer
- endometrial cancer models
